161 related articles for article (PubMed ID: 12651890)
1. G1 cyclin-dependent kinases are insufficient to reverse dE2F2-mediated repression.
Frolov MV; Stevaux O; Moon NS; Dimova D; Kwon EJ; Morris EJ; Dyson NJ
Genes Dev; 2003 Mar; 17(6):723-8. PubMed ID: 12651890
[TBL] [Abstract][Full Text] [Related]
2. A screen for modifiers of cyclin E function in Drosophila melanogaster identifies Cdk2 mutations, revealing the insignificance of putative phosphorylation sites in Cdk2.
Lane ME; Elend M; Heidmann D; Herr A; Marzodko S; Herzig A; Lehner CF
Genetics; 2000 May; 155(1):233-44. PubMed ID: 10790398
[TBL] [Abstract][Full Text] [Related]
3. p55, the Drosophila ortholog of RbAp46/RbAp48, is required for the repression of dE2F2/RBF-regulated genes.
Taylor-Harding B; Binné UK; Korenjak M; Brehm A; Dyson NJ
Mol Cell Biol; 2004 Oct; 24(20):9124-36. PubMed ID: 15456884
[TBL] [Abstract][Full Text] [Related]
4. dE2F2-independent rescue of proliferation in cells lacking an activator dE2F1.
Ambrus AM; Nicolay BN; Rasheva VI; Suckling RJ; Frolov MV
Mol Cell Biol; 2007 Dec; 27(24):8561-70. PubMed ID: 17923695
[TBL] [Abstract][Full Text] [Related]
5. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
6. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
[TBL] [Abstract][Full Text] [Related]
7. Functional antagonism between E2F family members.
Frolov MV; Huen DS; Stevaux O; Dimova D; Balczarek-Strang K; Elsdon M; Dyson NJ
Genes Dev; 2001 Aug; 15(16):2146-60. PubMed ID: 11511545
[TBL] [Abstract][Full Text] [Related]
8. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
9. Specific role of the SR protein splicing factor B52 in cell cycle control in Drosophila.
Rasheva VI; Knight D; Bozko P; Marsh K; Frolov MV
Mol Cell Biol; 2006 May; 26(9):3468-77. PubMed ID: 16611989
[TBL] [Abstract][Full Text] [Related]
10. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication.
Furstenthal L; Swanson C; Kaiser BK; Eldridge AG; Jackson PK
Nat Cell Biol; 2001 Aug; 3(8):715-22. PubMed ID: 11483956
[TBL] [Abstract][Full Text] [Related]
11. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.
Lundberg AS; Weinberg RA
Mol Cell Biol; 1998 Feb; 18(2):753-61. PubMed ID: 9447971
[TBL] [Abstract][Full Text] [Related]
12. Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression.
Jiang H; Chou HS; Zhu L
Mol Cell Biol; 1998 Sep; 18(9):5284-90. PubMed ID: 9710613
[TBL] [Abstract][Full Text] [Related]
13. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity.
Berns K; Hijmans EM; Bernards R
Oncogene; 1997 Sep; 15(11):1347-56. PubMed ID: 9315103
[TBL] [Abstract][Full Text] [Related]
14. Context-dependent requirement for dE2F during oncogenic proliferation.
Nicolay BN; Frolov MV
PLoS Genet; 2008 Oct; 4(10):e1000205. PubMed ID: 18833298
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2.
Lents NH; Keenan SM; Bellone C; Baldassare JJ
J Biol Chem; 2002 Dec; 277(49):47469-75. PubMed ID: 12359725
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
Keenan SM; Lents NH; Baldassare JJ
J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
[TBL] [Abstract][Full Text] [Related]
19. Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells.
Cheng L; Rossi F; Fang W; Mori T; Cobrinik D
J Biol Chem; 2000 Sep; 275(39):30317-25. PubMed ID: 10906146
[TBL] [Abstract][Full Text] [Related]
20. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
Morris TA; DeLorenzo RJ; Tombes RM
Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
